hormonal contraception

Navigating the Risks of Enzyme-Inducing Antiseizure Medications and Hormonal Contraceptive Interactions in Women with Epilepsy

By MedXY 10/13/2026

This article examines the prevalent coprescription of enzyme-inducing antiseizure medications (ASMs) and susceptible hormonal contraceptives among US Medicaid beneficiaries with epilepsy, highlighting patient risk factors and implications for clinical practice.

Internal Medicine news OB/GYN & Women’s Health

Expanding Contraceptive Access in Veterans Affairs: Pharmacist-Led Hormonal Contraception Provision and 12-Month Dispensing Pilot

By MedXY 07/12/2026

A VA pilot study shows that pharmacist-led provision and 12-month dispensing of hormonal contraception is feasible, improves access, and enhances satisfaction among women Veterans and pharmacists.

news OB/GYN & Women's Health Oncology

Hormonal Contraceptive Progestin Content Strongly Modifies Breast Cancer Risk in Adolescents and Premenopausal Women

By MedXY 11/12/2025

A Swedish nationwide cohort (n≈2.1M) found small but measurable variation in breast cancer risk by hormonal contraceptive formulation—higher with desogestrel/etonogestrel products and lower with levonorgestrel-containing devices; absolute excess risk remains small in women <50 years.